BRIEF-FMC AG – Refines China Commercial Strategy, Expects One-Time Costs Of €110 Million in Q3

4

Sept 25 (Reuters) – FRESENIUS MEDICAL CARE AG: * FMC AG – FRESENIUS MEDICAL CARE REFINES CHINA COMMERCIAL STRATEGY WITH A FOCUS ON LONG-TERM GROWTH AND MARKET LEADERSHIP * FMC AG – PORTFOLIO DECISIONS

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)